The Mst1 inhibition by luteolin leads to dephosphorylation of the Hippo pathway downstream transcription factors YAP/TAZ, which then enter the nucleus to activate mitochondrial biogenesis-related genes, improving mitochondrial function and thereby mitigating myocardial infarction injury. The gene discussed is MST1; the disease is myocardial infarction.